Delayed gastric ulcer healing associated with sirolimus [1]

Transplantation

Volumn 82, Issue 3, 2006, Pages 437-438

  Altomare, John F ^a   Smith, Robert E ^a   Potdar, Santosh ^a   Mitchell, Sara H ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PROTON PUMP INHIBITOR; RAPAMYCIN; TACROLIMUS;

AGED; ANGIODYSPLASIA; CASE REPORT; DIABETES MELLITUS; ESOPHAGOGASTRODUODENOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; PRIORITY JOURNAL; STOMACH ULCER; ULCER HEALING;

AGED; HUMANS; KIDNEY TRANSPLANTATION; MALE; SIROLIMUS; STOMACH ULCER; WOUND HEALING;

EID: 33747085524     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228900.24951.66     Document Type: Letter

References (6)

1. Sehgal SN, Sirolimus: Its Discovery, Biological Properties, and Mechanism of Action. Transplant Proc 2003; 35(Suppl 3A): 7S-14S.
2. Hardinger KL, Koch MJ, Brennan D. Current and Future Immunosuppressive Strategies in Renal Transplantation. Pharmacotherapy 2004; 24(9): 1159.
3. Cao W, Mohacsi P, Shorthouse R, et al. Effects of Rapamycin on Growth Factor-Stimulated Vascular Smooth Muscle Cell DNA synthesis. Transplantation 1995; 59(3): 390.
4. Product Information: Rapamune (Sirolimus) Oral Solution and Tablets. Philadelphia: Wyeth Laboratories, 2001.
5. Van Gelder T, Ter Meulen CG, Hene R, et al. Oral Ulcers in Kidney Transplant Recipients Treated with Sirolimus and Mycophenolate Mofetil. Transplantation 2003; 75(6): 788.
6. Dean PG, Lund WJ, Larson TS, et al. Wound-Healing Complications After Kidney Transplantation: A Prospective, Randomized Comparison of Sirolimus and Tacrolimus. Transplantation 2004; 77(10): 1555.